Current stock page

Financial Data

DOCS Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - Healthcare Information ServicesScore data as of Sep 4, 2026

DOCS

Financial Data
Doximity, Inc.
Healthcare· Medical - Healthcare Information Services
AIQ Score
NeutralAIQ Edge 9/10
Relative Leader / Watch
Strong Relative Position
Score data as of Sep 4, 2026
Last price
$26.35
-$0.75 (-2.77%)
Latest market quote
Momentum67
Value46
Quality77
Risk Resilience56
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 7, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$156.62M$145.37M$185.05M$168.53M$145.91M$138.29M$168.6M$136.83M
Gross Profit$132.93M$125.97M$166.35M$152.1M$130.12M$123.82M$154.42M$123.16M
Operating Income
Net Income$24.32M$19.11M$61.56M$62.06M$53.32M$62.46M$75.2M$44.15M
EPS$0.13$0.1$0.33$0.33$0.28$0.33$0.4$0.24
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow$41.99M$109.52M$60.89M$93.94M$62.1M$98.49M$65.19M$68.35M
Capital Expenditure-$62K-$2.25M$1.97M-$2.37M-$1.97M-$1.51M-$1.77M-$1.54M
Free Cash Flow$41.93M$107.27M$62.86M$91.58M$60.14M$96.98M$63.42M$66.8M
Net Cash Provided By Operating Activities$41.99M$109.52M$60.89M$93.94M$62.1M$98.49M$65.19M$68.35M
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$1.08B$1.12B$1.16B$1.26B$1.2B$1.26B$1.17B$1.12B
Total Debt$9.67M$10.19M$10.69M$11.27M$11.84M$12.4M$12.95M$13.49M
Cash And Cash Equivalents
Total Liabilities$167.78M$172.85M$177.73M$161.58M$178.85M$181.68M$141.04M$157.32M
Total Stockholders Equity$916.07M$950.84M$979.3M$1.1B$1.03B$1.08B$1.03B$961.2M
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio39.8858.2533.7158.9954.0643.7533.2245.95
P/B ratio4.134.538.4813.3711.2410.19.698.44
P/S ratio24.1829.6344.8686.8979.0379.0459.2759.31
Debt To Equity0.010.010.010.010.010.010.010.01
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio
P/B ratio4.134.538.4813.3711.2410.19.698.44
P/S ratio24.1829.6344.8686.8979.0379.0459.2759.31
Return On Equity2.65%2.01%6.29%5.66%5.20%5.77%7.29%4.59%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
29.61
multipleSep 4, 2026
Pb
5.25
multipleSep 4, 2026
Revenue Growth Yoy
7.74
percentSep 4, 2026
EPS Growth Yoy
30
percentSep 4, 2026
Gross Margin
88.07
percentSep 4, 2026
Operating Margin
29.6
percentSep 4, 2026
ROE
16.95
percentSep 4, 2026
ROIC
15.31
percentSep 4, 2026
Debt To Equity
0.01
ratioSep 4, 2026
FCF Yield
6.07
percentSep 4, 2026
Technical indicators
Close
26.35
priceSep 4, 2026
Volume
1,984,710
volumeSep 4, 2026
Rsi14
63.97
indexSep 4, 2026
MACD
0.97
indexSep 4, 2026
MACD Signal
0.97
indexSep 4, 2026
MACD Histogram
-0
indexSep 4, 2026
Adx14
39.74
indexSep 4, 2026
Sma50
23.3
priceSep 4, 2026
Sma200
28.86
priceSep 4, 2026
Atr14
1.36
priceSep 4, 2026
Historical Volatility
0.55
percentSep 4, 2026
Volume Ma20
3,477,574.7
volumeSep 4, 2026
Risk measures
Resilience Score
56
score_0_100Sep 4, 2026
Beta
1.21
ratioSep 4, 2026
Volatility Annual
63.21
percentSep 4, 2026
Max Drawdown
-76.03
percentSep 4, 2026
Sharpe Ratio
-1.26
ratioSep 4, 2026
Var95
-5.31
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

DOCS Financial Data FAQ

What is Doximity, Inc.'s revenue?

Doximity, Inc.'s revenue is one of the core financial data points for DOCS. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Doximity, Inc.'s revenue growing?

Revenue growth shows whether Doximity, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is DOCS's EPS?

DOCS's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Doximity, Inc.'s net income?

Doximity, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Doximity, Inc. generate?

Free cash flow shows how much cash Doximity, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Doximity, Inc. have?

Cash and debt help frame DOCS's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.